World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
81
Citations
23265
World Ranking
963
National Ranking
26

Medicine

D-Index
99
Citations
43078
World Ranking
8487
National Ranking
333

Wim Quint publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Wim Quint sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 237 publications — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Wim Quint D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Wim Quint sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 81 D-Index — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Wim Quint was affiliated with Erasmus University Rotterdam in the Netherlands. Their research primarily focused on medical science, with a strong emphasis on epidemiology, surgery, microbiology, oncology, and molecular biology. Their work spanned 115 publications in the broader field of medicine.

The scientist's research addressed multiple topics, including:

  • Cervical Cancer and HPV Research
  • Genital Health and Disease
  • Hepatitis B Virus Studies
  • Reproductive Tract Infections Research
  • Colorectal and Anal Carcinomas
  • Molecular Biology Techniques and Applications
  • Urological Disorders and Treatments

Wim Quint contributed to several well-regarded academic journals. The most frequent publication venues included:

  • International Journal of Cancer
  • JNCI Journal of the National Cancer Institute
  • The Lancet Oncology
  • Clinical Infectious Diseases
  • Acta Obstetricia Et Gynecologica Scandinavica

The scientist collaborated extensively with other researchers. Frequent coauthors included:

  • Rolando Herrero, with 21 joint publications
  • Carolina Porras, with 19 joint publications
  • Aimée R. Kreimer, with 19 joint publications
  • Allan Hildesheim, with 17 joint publications
  • John T. Schiller, with 17 joint publications

Their recent notable papers reflected their interests in human papillomavirus (HPV) and cancer risk. Selected publications are:

  • "Efficacy of the bivalent HPV vaccine against HPV 16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine Trial," published in The Lancet Oncology (2020)
  • "Methylation markers FAM19A4 and miR124-2 as triage strategy for primary human papillomavirus screen positive women: A large European multicenter study," published in the International Journal of Cancer (2020)
  • "Durability of Cross-Protection by Different Schedules of the Bivalent HPV Vaccine: The CVT Trial," published in the JNCI Journal of the National Cancer Institute (2020)
  • "molBV reveals immune landscape of bacterial vaginosis and predicts human papillomavirus infection natural history," published in Nature Communications (2022)
  • "Cancer Risk Stratification of Anal Intraepithelial Neoplasia in Human Immunodeficiency Virus-Positive Men by Validated Methylation Markers Associated With Progression to Cancer," published in Clinical Infectious Diseases (2020)

Best Publications

  • Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

    Silvia de Sanjose;Wim G.V. Quint;Laia Alemany;Daan T. Geraets

  • Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

    Diane M. Harper;Eduardo L. Franco;Cosette Wheeler;Daron Gale Ferris

  • Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

    Jorma Paavonen;David Jenkins;F. Xavier Bosch;Paulo Naud

  • The biology and life-cycle of human papillomaviruses.

    John Doorbar;Wim Quint;Lawrence Banks;Ignacio G. Bravo

  • Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori

    Leen–Jan van Doorn;Céu Figueiredo;Ricardo Sanna;Anton Plaisier

  • Helicobacter pylori and Interleukin 1 Genotyping: An Opportunity to Identify High-Risk Individuals for Gastric Carcinoma

    Céu Figueiredo;José Carlos Machado;Paul Pharoah;Raquel Seruca

  • HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients

    Xavier Castellsagué;Laia Alemany;Miquel Quer;Gordana Halec

  • Comprehensive control of human papillomavirus infections and related diseases.

    F. Xavier Bosch;Thomas R. Broker;David Forman;Anna Barbara Moscicki

  • GENUS AND SPECIES- SPECIFIC IDENTIFICATION OF MYCOPLASMAS BY 16S RRNA AMPLIFICATION

    F.J.M. van Kuppeveld;J.T.M. van der Logt;A.F. Angulo;M.J. van Zoest

  • Geographic distribution of vacA allelic types of Helicobacter pylori.

    Leen–Jan Van Doorn;Céu Figueiredo;Francis Mégraud;Salvador Pena

  • Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica.

    Rolando Herrero;Wim Quint;Allan Hildesheim;Paula Gonzalez

  • Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis.

    Mark A. Rubin;Bernard Kleter;Ming Zhou;Gustavo Ayala

  • Molecular diagnosis of human papillomavirus (HPV) infections.

    Anco Molijn;Berhard Kleter;Wim Quint;Leen-Jan van Doorn

  • Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma.

    Edyta C. Pirog;Bernhard Kleter;Semra Olgac;Piotr Bobkiewicz

  • Proof-of-Principle Evaluation of the Efficacy of Fewer Than Three Doses of a Bivalent HPV16/18 Vaccine

    Aimée R. Kreimer;Ana Cecilia Rodriguez;Allan Hildesheim;Rolando Herrero

  • Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva

    Silvia De Sanjosé;Laia Alemany;Jaume Ordi;Sara Tous

  • Expanding Allelic Diversity of Helicobacter pylori vacA

    Leen Jan Van Doorn;Céu Figueiredo;Ricardo Sanna;Salvador Pena

  • Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: A randomized, controlled trial

    Diane M. Harper;Eduardo L. Franco;Cosette Wheeler;Daron G. Ferris

  • Human Papillomavirus Infection with Multiple Types: Pattern of Coinfection and Risk of Cervical Disease

    Anil K. Chaturvedi;Hormuzd A. Katki;Allan Hildesheim;Ana Cecilia Rodríguez

  • Human Papillomavirus Genotype Distributions: Implications for Vaccination and Cancer Screening in the United States

    Cosette M. Wheeler;William C. Hunt;Nancy E. Joste;Charles R. Key

Frequent Co-Authors

Mark Schiffman
Mark Schiffman National Institutes of Health
Allan Hildesheim
Allan Hildesheim National Institutes of Health
Silvia de Sanjosé
Silvia de Sanjosé University of Barcelona
Rolando Herrero
Rolando Herrero Costa Rican Agency for Biomedical Research, INCIENSA Foundation
Chris J.L.M. Meijer
Chris J.L.M. Meijer Vrije Universiteit Amsterdam
Willem J. G. Melchers
Willem J. G. Melchers Radboud University
Michael Pawlita
Michael Pawlita German Cancer Research Center
Sholom Wacholder
Sholom Wacholder National Institutes of Health
John T. Schiller
John T. Schiller National Institutes of Health
Peter J.F. Snijders
Peter J.F. Snijders Vrije Universiteit Amsterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Molecular Biology opens the door to many diverse career paths. Beyond laboratory research and teaching, graduates can apply their scientific insight to areas like healthcare, mental health, and social services. Today, flexible learning options make it easier to pivot into these fields or upskill for new roles.

For those seeking a quick route to advanced credentials, there are fast track masters in psychology and accelerated online masters in counseling degree programs. These options allow graduates to qualify for specialized roles in areas where a science background is highly valued, such as mental health counseling or clinical psychology.

If you’re interested in working with communities, consider exploring social work master programs online. These programs can expand your impact beyond the laboratory, preparing you to support individuals and families facing health, social, or emotional challenges.

Active-duty military and veterans may find tailored support and flexible schedules at some of the best online colleges for military, making transitions into science or allied fields more accessible.

Best Scientists Citing Wim Quint

Recently Published Articles